secondary procedures | secondary school approaches | secondary school methods | secondary school procedures

post-secondary school methods | post-secondary school processes | post-secondary procedures | post-secondary school procedures

secondary center | secondary centre | secondary exchange | secondary switching center | secondary switching centre | SC [Abbr.]

secondary somatosensory cortex [ S2,SII | secondary somatic sensory cortex | secondary somesthetic cortex | secondary somatosensory area | secondary somatic sensory area | secondary somesthetic area ]

haemolytic anaemia secondary to G6PD deficiency | haemolytic anaemia secondary to glucose-6-phosphate dehydrogenase deficiency | hemolytic anemia secondary to G6PD deficiency | hemolytic anemia secondary to glucose-6-phosphate dehydrogenase deficiency

secondary cooling | secondary cooling system | secondary cooling zone | secondary spray zone

manage secondary school departments | managing secondary school department | manage secondary school department | manages secondary school department

national secondary ambient air quality standard [ national secondary standard | secondary ambient air quality standard | secondary standard ]

disodium hydrogenphosphate [ dibasic sodium phosphate | disodium orthophosphate | disodium phosphate | secondary sodium phosphate | phosphate of soda | secondary sodium orthophosphate | sodium orthophosphate secondary | sodium phosphate dibasic | sodium phosphate secondary ]

secondary recovery | secondary exploitation | secondary production | secondary operation

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) ho ...[+++]w is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...

Motions cannot have ulterior motives, but it has a secondary purpose, and its secondary purpose has to be to seek to ask the Standing Committee on Rules, Procedures and the Rights of Parliament to nullify the proceedings of another committee, being the committee that Senator Banks chairs.

Given that the proposed instrument is directed to both developing countries and non-developing third countries and that the procedures provided by the two articles are consistent (qualified majority vote in the Council), Article 181a could be used as legal basis in conjunction with Article 179 since the instrument in question pursues several contemporaneous objectives which are indissolubly linked with each other without one being secondary and indirect in respect of the others. In this case the codecision procedure would apply to the ...[+++] whole instrument.

The requisite majorities may not therefore be set either by the drafters of secondary law or by Parliament in its Rules of Procedure.